COM:PLURI-BIOTECH
Pluri Biotech Ltd.
- Stock
Last Close
4.85
22/11 21:00
Market Cap
30.92M
Beta: -
Volume Today
2.59K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '14 | Jun '15 | Jun '16 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 2.46M - | 2.46M 0% | 134.50K - | |||||||||
average payables | 3.15M - | 3.37M 6.84% | 2.99M 11.29% | 2.34M 21.80% | 2.61M 11.90% | 2.77M 6.03% | 2.12M 23.33% | 2.25M 5.77% | 2.16M 4.07% | 1.80M 16.56% | 1.39M 22.82% | |
average receivables | 1.13M - | 2.39M 110.83% | 2.49M 4.57% | 1.83M 26.74% | 1.01M 44.71% | 1.13M 12.22% | 1.52M 33.64% | 1.55M 2.28% | 1.41M 9.32% | 924K 34.26% | 586.50K 36.53% | |
book value per share | 9.78 - | 8.27 15.42% | 4.80 42.02% | 3.46 27.86% | 2.69 22.19% | 1.77 34.29% | 3.08 74.24% | 2.03 34.06% | 0.93 54.10% | 0.36 60.95% | 1.03 183.60% | |
capex per share | -0.25 - | -0.12 52.26% | -0.22 86.07% | -0.04 80.35% | -0.03 25.29% | -0.02 40.01% | -0.01 23.44% | -0.01 10.58% | -0.01 34.44% | -0.01 17.81% | 0.06 962.28% | |
capex to depreciation | -0.83 - | -0.40 51.55% | -0.81 103.15% | -0.17 78.67% | -0.17 2.40% | -0.12 28.12% | -0.17 41.18% | -0.27 58.32% | -0.27 2.33% | -0.72 172.18% | 1.28 276.40% | |
capex to operating cash flow | 0.08 - | 0.04 50.98% | 0.09 134.27% | 0.02 81.49% | 0.02 8.55% | 0.01 49.27% | 0.01 26.18% | 0.01 17.85% | 0.01 36.43% | 0.01 49.43% | -0.02 256.37% | |
capex to revenue | -4.15 - | -2.19 47.17% | -0.61 71.97% | -6.84 - | -4.43 35.29% | -11.74 165.24% | -1.20 - | -0.91 23.71% | 0.99 208.53% | |||
cash per share | 8.49 - | 7.40 12.75% | 4.05 45.32% | 2.99 26.25% | 2.82 5.43% | 1.92 31.94% | 2.52 30.90% | 2.31 8.18% | 1.71 26.03% | 1.10 35.87% | 5.72 422.08% | |
days of inventory on hand | 163.06K - | |||||||||||
days payables outstanding | 114.97K - | 91.76K 20.20% | 9.87K 89.24% | 595.13K - | 416.28K 30.05% | 18.21 - | 15.66 13.99% | 73.49K 469,034.86% | 87.97K 19.70% | |||
days sales outstanding | 2.18K - | 2.42K 10.83% | 318.08 86.83% | 6.18K - | 9.60K 55.34% | 25.55K 166.01% | 2.06K - | 670.23 67.47% | 723.28 7.92% | |||
debt to assets | 0.02 - | 0.26 986.65% | 0.42 61.00% | 0.59 39.13% | 0.75 27.25% | |||||||
debt to equity | 0.03 - | 0.43 1,422.54% | 0.96 122.90% | 2.24 133.54% | 308.46 13,675.16% | |||||||
dividend yield | ||||||||||||
earnings yield | -0.14 - | -0.14 2.52% | -0.22 57.70% | -0.25 13.12% | -0.20 18.62% | -0.48 139.26% | -0.18 62.30% | -0.45 145.89% | -1.04 130.95% | -0.96 7.00% | -0.69 28.17% | |
enterprise value | 193.67M - | 154.49M 20.23% | 99.58M 35.55% | 107.20M 7.66% | 120.35M 12.27% | 68.66M 42.95% | 154.18M 124.56% | 104.67M 32.11% | 58.63M 43.99% | 53.94M 7.99% | 53.01M 1.72% | |
enterprise value over ebitda | -7.27 - | -6.52 10.31% | -4.71 27.77% | -4.12 12.38% | -3.01 27.01% | -2.05 31.79% | -5.60 172.52% | -2.15 61.65% | -1.47 31.66% | -2.09 42.50% | -2.59 23.77% | |
ev to operating cash flow | -10.13 - | -7.50 25.98% | -5.38 28.30% | -4.96 7.73% | -5.63 13.48% | -2.33 58.59% | -5.85 150.82% | -3.39 42.08% | -1.61 52.57% | -2.36 46.93% | -2.94 24.66% | |
ev to sales | 511.01 - | 407.63 20.23% | 34.98 91.42% | 2.41K - | 1.27K 47.18% | 6.70K 427.23% | 250.54 - | 187.94 24.98% | 162.62 13.48% | |||
free cash flow per share | -3.26 - | -3.05 6.39% | -2.55 16.44% | -2.52 1.30% | -2.05 18.43% | -2.41 17.35% | -1.46 39.20% | -1.11 23.99% | -1.14 2.68% | -0.63 44.79% | -3.50 454.97% | |
free cash flow yield | -0.10 - | -0.12 15.90% | -0.19 58.32% | -0.20 2.55% | -0.17 14.42% | -0.41 142.65% | -0.17 59.42% | -0.28 69.68% | -0.93 230.58% | -0.79 15.33% | -0.61 22.73% | |
graham net net | 7.27 - | 6.25 14.03% | 3.30 47.11% | 2.25 31.79% | 1.90 15.84% | 1.24 34.67% | 2.06 66.58% | 1.06 48.85% | 0.63 40.78% | 0.14 77.88% | -0.70 602.58% | |
graham number | 30.55 - | 25.56 16.31% | 17.76 30.53% | 15.74 11.38% | 12.23 22.31% | 10.66 12.80% | 10.58 0.79% | 9.01 14.78% | 5.17 42.62% | 2.52 51.34% | 1.28 49.07% | |
income quality | 0.71 - | 0.83 17.61% | 0.80 4.58% | 0.78 2.48% | 0.82 5.32% | 0.83 1.94% | 0.90 8.43% | 0.62 31.47% | 0.88 42.32% | 0.79 10.31% | 0.84 6.71% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -150.39 - | -649.01 331.56% | -46.89 92.77% | -32.32 31.07% | -25.59 20.83% | |||||||
interest debt per share | 0.10 - | 0.88 796.30% | 0.92 5.13% | 0.84 9.04% | 5.82 593.29% | |||||||
inventory turnover | 0.00 - | |||||||||||
invested capital | 0.03 - | 0.43 1,422.54% | 0.96 122.90% | 2.24 133.54% | 33.90M 1,513,864,287.23% | |||||||
market cap | 198.16M - | 177.12M 10.62% | 105.80M 40.27% | 111.91M 5.77% | 129.17M 15.43% | 72.76M 43.67% | 160.86M 121.08% | 111.33M 30.79% | 39.60M 64.43% | 29.39M 25.76% | 30.18M 2.68% | |
net current asset value | 50.09M - | 46.86M 6.45% | 27.81M 40.65% | 21.73M 21.85% | 21.58M 0.69% | 16.88M 21.78% | 39.03M 131.19% | 30.98M 20.61% | 21.87M 29.42% | 5.91M 72.97% | -3.00M 150.83% | |
net debt to ebitda | 0.17 - | 0.95 466.20% | 0.29 69.18% | 0.18 38.44% | 0.22 21.84% | 0.12 44.35% | 0.24 97.58% | 0.14 43.75% | -0.48 448.78% | -0.95 99.77% | -1.11 17.13% | |
net income per share | -4.24 - | -3.51 17.20% | -2.92 16.77% | -3.18 8.87% | -2.47 22.44% | -2.86 15.71% | -1.61 43.51% | -1.78 10.15% | -1.27 28.27% | -0.77 39.36% | -3.99 415.86% | |
operating cash flow per share | -3.01 - | -2.93 2.62% | -2.33 20.58% | -2.47 6.16% | -2.02 18.31% | -2.39 18.27% | -1.45 39.32% | -1.10 24.13% | -1.13 3.13% | -0.62 45.00% | -3.44 451.45% | |
payables turnover | 0.00 - | 0.00 25.31% | 0.04 829.33% | 0.00 - | 0.00 42.96% | 20.04 - | 23.30 16.27% | 0.00 99.98% | 0.00 16.46% | |||
receivables turnover | 0.17 - | 0.15 9.77% | 1.15 659.36% | 0.06 - | 0.04 35.63% | 0.01 62.41% | 0.18 - | 0.54 207.44% | 0.50 7.34% | |||
research and ddevelopement to revenue | 51.56 - | 50.59 1.89% | 6.88 86.41% | 452.58 - | 489.39 8.13% | 938.13 91.69% | 104.18 - | 54.86 47.34% | 38.18 30.41% | |||
return on tangible assets | -0.36 - | -0.36 0.48% | -0.51 39.75% | -0.74 46.45% | -0.67 9.51% | -1.12 67.71% | -0.45 60.18% | -0.53 19.22% | -0.60 12.88% | -0.56 7.49% | -0.53 5.22% | |
revenue per share | 0.06 - | 0.05 9.63% | 0.36 563.71% | 0.00 - | 0.00 7.28% | 0.00 71.13% | 0.01 - | 0.01 7.73% | 0.06 694.48% | |||
roe | -0.43 - | -0.42 2.10% | -0.61 43.55% | -0.92 50.92% | -0.92 0.32% | -1.61 76.08% | -0.52 67.58% | -0.87 67.05% | -1.37 56.28% | -2.12 55.28% | -217.58 10,160.32% | |
roic | -0.43 - | -0.42 2.04% | -0.61 43.63% | -0.92 50.91% | -1.53 66.16% | -1.62 6.30% | -0.50 69.17% | -0.61 22.80% | -0.63 1.69% | -0.55 11.36% | -0.76 37.17% | |
sales general and administrative to revenue | 22.89 - | 17.04 25.54% | 2.28 86.63% | 223.86 - | 169.57 24.25% | 344.43 103.12% | 74.57 - | 41.04 44.96% | 30.78 25.01% | |||
shareholders equity per share | 9.78 - | 8.27 15.42% | 4.80 42.02% | 3.46 27.86% | 2.69 22.19% | 1.77 34.29% | 3.08 74.24% | 2.03 34.06% | 0.93 54.10% | 0.36 60.95% | 0.02 94.97% | |
stock based compensation to revenue | 15.44 - | 10.69 30.75% | 1.08 89.90% | 130.96 - | 95.30 27.23% | 111.39 16.89% | 38.07 - | 13.86 63.60% | 8.03 42.05% | |||
tangible asset value | 62.12M - | 58.14M 6.41% | 38.16M 34.38% | 30.25M 20.72% | 28.51M 5.77% | 21.82M 23.45% | 56.10M 157.10% | 57.15M 1.87% | 32.19M 43.68% | 15.30M 52.46% | 5.42M 64.61% | |
tangible book value per share | 9.78 - | 8.27 15.42% | 4.80 42.02% | 3.46 27.86% | 2.69 22.19% | 1.77 34.29% | 3.08 74.24% | 2.03 34.06% | 1.00 50.82% | 0.42 58.25% | 1.03 147.54% | |
working capital | 54.59M - | 50.69M 7.15% | 29.82M 41.16% | 23.60M 20.85% | 23.49M 0.48% | 18.21M 22.46% | 40.47M 122.23% | 55.85M 38.00% | 50.92M 8.84% | 35.79M 29.71% | 26.65M 25.53% |
All numbers in (except ratios and percentages)